Kane Biotech Investor Relations Material

Kane Biotech Inc. is a biotechnology company engaged in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms. Biofilms are complex communities of bacteria that can adhere to surfaces and are resistant to antibiotics and chemical agents. Kane Biotech's portfolio includes solutions for human health, animal health, and industrial applications, focusing on addressing challenges related to biofilm-related infections and contamination. The company is headquartered in Winnipeg, Canada, and its shares are listed on the TSX.